Product image of Afqlir (Aflibercept) supplied by GNH India

Afqlir

Active Ingredient:
Aflibercept
Origin:
EU

Afqlir (Aflibercept)

Afqlir is a pharmaceutical product containing aflibercept, used primarily for intravitreal administration. It is designed to address specific eye conditions by targeting vascular endothelial growth factor (VEGF).

Manufacturer / TM Owner

Sandoz Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Afqlir is generally used for the treatment of certain eye conditions that involve abnormal blood vessel growth within the retina. This medication works by inhibiting VEGF, a protein that promotes the growth of new blood vessels. It is often prescribed for conditions such as wet age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion.

Side Effects

  • Common effects of Afqlir may include temporary vision disturbances, eye redness, and discomfort at the injection site. Some users might experience floaters or increased eye pressure. These effects are typically mild and transient, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

  • Afqlir should be handled with care and administered by a healthcare professional. It is important to follow all safety guidelines provided by the manufacturer and healthcare provider. Patients should inform their healthcare provider about any allergies or medical conditions before using this medication.

Avoid Interactions

  • Afqlir may interact with other medications, particularly those that affect blood clotting or immune response. It is advisable to discuss all current medications with a healthcare provider before starting treatment with Afqlir. Additionally, patients should avoid activities that may increase the risk of eye injury during the treatment period.

Frequently Asked Questions

Afqlir is used to treat certain eye conditions involving abnormal blood vessel growth in the retina, such as wet age-related macular degeneration and diabetic macular edema.

Afqlir is administered through intravitreal injection, which is performed by a healthcare professional.

Common side effects may include temporary vision disturbances, eye redness, and discomfort at the injection site.

Afqlir may interact with other medications, so it is important to discuss all current medications with a healthcare provider before starting treatment.

Afqlir is manufactured by Sandoz Gmbh.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Aflibercept

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT